Genital fistulas in female Crohn's disease patients.. Clinical characteristics and response to therapy

Journal of Crohn's and Colitis

Volumn 6, Issue 3, 2012, Pages 276-280

  De la Poza, Gema ^a,e   López Sanroman, Antonio ^a   Taxonera, Carlos ^b   Marín Jimenez, Ignacio ^c   P Gisbert, Javier ^d   Bermejo, Fernando ^e   Opio, Verónica ^f   Muriel, Alfonso ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

^f HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Crohn's disease; Fistula; Inflammatory bowel disease

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; CERTOLIZUMAB PEGOL; CIPROFLOXACIN; GLUCOCORTICOID; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; METRONIDAZOLE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANOVAGINAL FISTULA; ANOVULVAR FISTULA; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CROHN DISEASE; ENTEROVAGINAL FISTULA; FECES; FEMALE; FISTULA; GENITAL FISTULA; GYNECOLOGIC DISEASE; GYNECOLOGIC SURGERY; HUMAN; PRIORITY JOURNAL; RECTOVAGINAL FISTULA; REOPERATION; SMOKING; TREATMENT RESPONSE; VAGINA DISCHARGE;

ADOLESCENT; ADULT; AGE FACTORS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CIPROFLOXACIN; CROHN DISEASE; FEMALE; FISTULA; HUMANS; INTESTINAL FISTULA; METRONIDAZOLE; PURINES; RECTAL FISTULA; RECTOVAGINAL FISTULA; RETROSPECTIVE STUDIES; SMOKING; TIME FACTORS; TREATMENT FAILURE; TUMOR NECROSIS FACTOR-ALPHA; VAGINAL FISTULA; VULVAR DISEASES; YOUNG ADULT;

EID: 84858081927     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.08.015     Document Type: Article

References (27)

1. Schwartz D.A., Loftus E.V., Tremaine W.J., Panaccione R., Harmsen W.S., Zinsmeister A.R., Sandborn W.J. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002, 122:875-880.
2. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., Caprilli R., Colombel J.F., Gasche C., Geboes K., Jewell D.P., Karban A., Loftus E.V., Peña A.S., Riddell R.H., Sachar D.B., Schreiber S., Steinhart A.H., Targan S.R., Vermeire S., Warren B.F. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl A):5-36.
3. Platell C., Mackay J., Collopy B., Fink R., Ryan P., Woods R. Anal pathology in patients with Crohn's disease. Aust N Z J Surg 1996, 66:5-9.
4. Radcliffe A.G., Ritchie J.K., Hawley P.R., Lennard-Jones J.E., Northover J.M. Anovaginal and rectovaginal fistulas in Crohn's disease. Dis Colon Rectum 1988, 31:94-99.
5. Andreani S.M., Dang H.H., Grondona P., Khan A.Z., Edwards D.P. Rectovaginal fistula in Crohn's disease. Dis Colon Rectum 2007, 50:2215-2222.
6. a edición.
7. Pinto R., Peterson T., Shawki S., Davila W., Wexner S. Are there predictors of outcome following rectovaginal fistula repair. Dis Colon Rectum 2010, 53:1240-1247.
8. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989, 24:2-6.
9. American Gastroenterological Association American Gastroenterological Association Medical Position Statement: perianal Crohn's disease. Gastroenterology 2003, 125:1503-1507.
10. Caprilli R., Gassull M.A., Escher J.C., Moser G., Munkholm P., Forbes A., Hommes D.W., Lochs H., Angelucci E., Cocco A., Vucelic B., Hildebrand H., Kolacek S., Riis L., Lukas M., de Franchis R., Hamilton M., Jantschek G., Michetti P., O'Morain C., Anwar M.M., Freitas J.L., Mouzas I.A., Baert F., Mitchell R., Hawkey C.J. European Crohn's and Colitis Organization European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006, 55(Suppl 1):i36-i58.
11. Turunen U., Farkkila M., Seppala K. Long term treatment of perianal or fistulous Crohn's disease with ciprofloxacin. Scand J Gastroenterol 1989, 24:144.
12. Wolf J.L. Ciprofloxacin may be useful in Crohn's disease. Gastroenterology 1990, 98:A212.
13. Solomon M.J., Mc Leod R.S., O'Connor B.I., Steinhart A., Greenberg G., Cohen Z. Combination ciprofloxacin and metronidazole in severe perianal Crohn's disease. Scand J Gastroenterol 1993, 7:571-573.
14. Present D.H., Korelitz B.I., Wisch N., Glass J.L., Sachar D.B., Pastermack B.S. Treatment of Crohn's disease with 6-mercaptopurine. A long-term randomized double blind study. N Engl J Med 1980, 302:981-987.
15. O'Brien J., Bayless T., Bayless J. Use of azathioprine in the treatment of Crohn's disease. Gastroenterology 1991, 101:39-46.
16. Present D.H., Lichtiger S. Efficacy of cyclosporine in treatment of fistula of Crohn's disease. Dig Dis Sci 1994, 39:374-380.
17. Hanauer S.B., Smith M.B. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporine A. Am J Gastroenterol 1993, 88:646-649.
18. Egan L.J., Sandborn W.J., Tremaine W.J. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine. Am J Gastroenterol 1998, 93:442-448.
19. Sands B.E., Blank M.A., Patel K., van Deventer S.J. Longterm treatment of rectovaginal fistulas in Crohn's Disease: response to infliximab in the ACCENT II study. Clin Gastroenterol Hepatol 2004, 2:912-920.
20. Parsi M., Lashner B., Achkar J.P., Connor J.T., Brzezinski A. Type of fistula determines response to infliximab in patients with fistulous Crohn's Disease. Am J Gastroenterol 2004, 99:445-449.
21. Van Bodegraven A.A., Sloots C.E., Felt-Bersma R.J., Meuwissen S.G. Endosonographic evidence of persistence of Crohn's disease associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum 2002, 45:39-45.
22. Ricart E., Panaccione R., Loftus E.V., Tremaine W.J., Sandborn W.J. Infliximab for Crohn_s disease in clinical practice at the Mayo Clinic: the first 100 patients. Am J Gastroenterol 2001, 96:722-729.
23. Bell S.J., Halligan S., Windsor A.C., Williams A.B., Wiesel P., Kamm M.A. Response of fistulating Crohn's disease to infliximab treatment assessed by MRI. Aliment Pharmacol Ther 2003, 17:387-393.
24. Topstad D.R., Panaccione R., Heine J.A., Johnson D.R., MacLean A.R., Buie W.D. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Dis Colon Rectum 2003, 46:577-583.
25. Ciga M.A., Oteiza F., Marzo J., Armendáriz P., De Miguel M., Ortiz H. Tratamiento de la enfermedad de Crohn perianal. An Sist Sanit Navar 2006, 29367-29386.
26. Yamamoto T., Allan R., Keighley M. Audit of single-stage proctocolectomy for Crohn's disease: postoperative complications and recurrence. Dis Colon Rectum 2000, 43:249-256.
27. Mahid S.S., Minor K.S., Soto R.E., Hornung C.A., Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006, 81:1462-1471.